Objective To better understand the consequences of returning whole genome sequencing (WGS) results in paediatrics and facilitate its evidence-based clinical implementation, we studied parents' experiences with WGS and their preferences for the return of adult-onset secondary variants (SVs)—medically actionable genomic variants unrelated to their child's current medical condition that predict adult-onset disease.
Methods We conducted qualitative interviews with parents whose children were undergoing WGS as part of the SickKids Genome Clinic, a research project that studies the impact of clinical WGS on patients, families, and the healthcare system. Interviews probed parents' experience with and motivation for WGS as well as their preferences related to SVs. Interviews were analysed thematically.
Results Of 83 invited, 23 parents from 18 families participated. These parents supported WGS as a diagnostic test, perceiving clear intrinsic and instrumental value. However, many parents were ambivalent about receiving SVs, conveying a sense of self-imposed obligation to take on the ‘weight’ of knowing their child's SVs, however unpleasant. Some parents chose to learn about adult-onset SVs for their child but not for themselves.
Conclusions Despite general enthusiasm for WGS as a diagnostic test, many parents felt a duty to learn adult-onset SVs. Analogous to ‘inflicted insight’, we call this phenomenon ‘inflicted ought’. Importantly, not all parents of children undergoing WGS view the best interests of their child in relational terms, thereby challenging an underlying justification for current ACMG guidelines for reporting incidental secondary findings from whole exome and WGS.
- Genetic Screening/Testing
- Genetic Information
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors All authors have substantial contributions to the conception or design of the work; the acquisition, analysis or interpretation of data for the work; drafted the work or revised it critically for important intellectual content; provided final approval of the version to be published; and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Funding McLaughlin Centre, University of Toronto (MC-2013-15).
Competing interests None.
Ethics approval The Research Ethics Board of The Hospital for Sick Children, Toronto, Canada.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Genomic intensive care: should we perform genome testing in critically ill newborns?
- Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases
- The genetic assessment of looked after children: common reasons for referral and recent advances
- Defining and managing incidental findings in genetic and genomic practice
- Delivering genome sequencing in clinical practice: an interview study with healthcare professionals involved in the 100 000 Genomes Project
- Cancer patients’ views and understanding of genome sequencing: a qualitative study
- Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases
- Pathogenic variants in the healthy elderly: unique ethical and practical challenges
- The challenge of consent in clinical genome-wide testing
- Whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: a roadmap